Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

B Gückel; S Stumm; C Rentzsch; S Kayser; I Gruber; A Marmé; J Huober; F Autschbach; S Meuer; D Wallwiener

首页> 外文期刊>Cancer Cell International >Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

【24h】

Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

机译：使用基因修饰的同种异体乳腺癌细胞进行I / II期疫苗接种试验的开发，监测和首次免疫学结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer Cell International》 |2004年第1期|共页
作者
B Gückel; S Stumm; C Rentzsch; S Kayser; I Gruber; A Marmé; J Huober; F Autschbach; S Meuer; D Wallwiener;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Outcome of Children with Primary Immune-Deficiencies (PIDs) Enrolled in a Phase I-II Trial Based on the Infusion of BPX-501 Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) after T-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (haplo-HSCT) [J] . Kapoor Neena, Bertaina Alice, Merli Pietro, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：基于I-II型试验的主要免疫缺陷（PIDS）的结果基于BPX-501供体T细胞的输注，在T细胞耗尽HLA后遗传修饰的BPX-501供体T细胞遗传修饰（诱导型胱天蛋白酶9，IC9） -haploidentical同种异体干细胞移植（HAPLO-HSCT）
2. Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial [J] . Morena Antonilli, Hassan Rahimi, Valeria Visconti, International journal of oncology . 2016,第4期

机译：三肽疫苗接种作为合并治疗的卵巢癌和乳腺癌妇女：I / II期临床试验的临床和免疫学数据
3. Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer. [J] . Hardy NM, Steinberg SM, Yan XY, Clinical cancer research: an official journal of the American Association for Cancer Research . 2011,第21期

机译：用于转移性乳腺癌的混合型I / II型异体T细胞过继性细胞转移的I期试验。
4. Direct Detection of Metabolic Changes in Genetically Modified Triple-Negative Breast Cancer Cells by Laser Ablation Electrospray Ionization Mass Spectrometry [C] . Hang Li, Hehua Huang, Bindesh Shrestha, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：通过激光烧蚀电喷雾电离质谱法直接检测遗传改性三重阴性乳腺癌细胞的代谢变化
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial [O] . MORENA ANTONILLI, HASSAN RAHIMI, VALERIA VISCONTI, -1

机译：三肽疫苗接种作为合并治疗的卵巢癌和乳腺癌妇女：I / II期临床试验的临床和免疫学数据
7. Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells [O] . 2004

机译：使用基因改造的同种异体乳腺癌细胞进行I / II期疫苗接种试验的开发，监测和首次免疫学结果

Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

著录项

相似文献

相关主题

期刊订阅